TMCnet News

Axiom Presents "Benefits and Advantages of a Unified Platform Approach to Global Studies" at BIO Digital 2021
[June 10, 2021]

Axiom Presents "Benefits and Advantages of a Unified Platform Approach to Global Studies" at BIO Digital 2021


TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at BIO Digital 2021, the world's largest virtual biotech partnering and education event. Welcoming thousands of global biotech leaders and innovators from June 14 to 18, this year's conference will spotlight biotech's transformative role and impact on today's four key challenges – COVID, social justice, the economy and climate change.

During the event, Axiom will have an on-demand presentation available for viewing titled "Benefits and Advantages of a Unified Platform Approach to Global Studies", presented by Axiom's Heather DiFruscia, Associate Director of RTSM/IWRS and Brian Dempster, Senior Director of Global Clinical Management. This session will highlight the critical challenges of conducting studies globally and demonstrate how a truly unified eClinical platform can tackle these challenges.

"Regulatory differences in each region is the biggest obstacle to overcome if you are setting up a global study for the first time," Dempster shared. "You cannot superimpose your understanding and expectations of one region on another since global studies are beyond just an expansion of a regional study scaled up to a global scope. It is important to understand and appreciate the nuanced cultural differences in those regions, particularly if youare looking to set up a global trial outside your region for the first time. Working with a partner who already has the global experience and local expertise is highly recommended."



“When conducting global studies, there are many roadblocks including managing and monitoring global patient data and establishing communication standards,” DiFruscia commented. “A truly unified platform can bring you the drill-down and global awareness of your critical data with real-time notifications. With real-time visibility into your study data and site activities, your team can identify and make course corrections or adjustments sooner. In our presentation, we will demonstrate some of the critical modules from our Fusion eClinical Suite that help you to tackle these challenges head on.”

Learn more about Axiom’s fully unified Fusion eClinical Suite: https://www.axiommetrics.com/fusion-eclinical-suite/


About Axiom Real-Time Metrics

Axiom is celebrating its 20th anniversary after delivering hundreds of studies in dozens of countries.
Since 2001, Axiom has delivered data-driven, powerful and cost-effective eClinical Solutions and Services dedicated to small-to-medium life science companies. Fusion eClinical Suite is the most adaptable, unified platform that serves as the Connected Hub for all your Clinical Trial and operational data and reporting. Choose from over 15 fully integrated modules on a single platform: EDC, DM, RTSM/IWRS, CTMS, Inventory Management, ePRO, eConsent, Patient Portal, AE/SAE Tracking, Safety Database, Central/Local Lab, Imaging Management, eTMF, and 24/7 Project and Clinical Data Reporting. We are an embedded partner dedicated to the success of your study, offering managed services such as: Data Management, On-Demand Data Analytics, Biostatistics, Clinical Management, eTMF Management and Pharmacovigilance.

For more information, please visit https://www.axiommetrics.com

PR Contact

Angel Tian

pr@axiom.cc

+1.647.206.7307


Primary Logo


[ Back To TMCnet.com's Homepage ]